Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Nov;7(4):221-33.
doi: 10.2174/157340311799960636.

Cardiotoxicity of molecularly targeted agents

Nadia Hedhli  1 , Kerry S Russell
Affiliations
Review

Cardiotoxicity of molecularly targeted agents

Nadia Hedhli et al. Curr Cardiol Rev. 2011 Nov.

Abstract

Cardiac toxicity of molecularly targeted cancer agents is increasingly recognized as a significant side effect of chemotherapy. These new potent therapies may not only affect the survival of cancer cells, but have the potential to adversely impact normal cardiac and vascular function. Unraveling the mechanisms by which these therapies affect the heart and vasculature is crucial for improving drug design and finding alternative therapies to protect patients predisposed to cardiovascular disease. In this review, we summarize the classification and side effects of currently approved molecularly targeted chemotherapeutics.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ewer MS, Lippman SM. Type II chemotherapy-related cardiac dysfunction time to recognize a new entity. J Clin Oncol. 2005;23(13 ):2900–2. - PubMed
    1. Telli ML, Hunt SA, Carlson RW, Guardino AE. Trastuzumab-related cardiotoxicity calling into question the concept of reversibility. J Clin Oncol. 2007;25(23 ):3525–33. - PubMed
    1. Hunter T, Cooper JA. Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells. Cell. 1981;24:741–52. - PubMed
    1. Schreiber AB, Lax I, Yarden Y, Eshhar Z, Schlessinger J. Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effects of epidermal growth factor. Proc Natl Acad Sci U S A. 1981;78(12 ):7535–9. - PMC - PubMed
    1. Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Mendelsohn J. Growth stimulation of A431 cells by epidermal growth factor identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci U S A. 1983;80(5 ):1337–41. - PMC - PubMed

Publication types

MeSH terms